{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:06:54Z","timestamp":1789204014353,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijmmb.2026.101219","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:23:33Z","timestamp":1784071413000},"page":"101219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence and serological profile of occult hepatitis B virus infection in newly diagnosed cancer patients"],"prefix":"10.1016","volume":"63","author":[{"given":"Subhashree","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8123-2350","authenticated-orcid":false,"given":"Shilpee","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2026.101219_bib1","series-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","year":"2024"},{"key":"10.1016\/j.ijmmb.2026.101219_bib2","series-title":"Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection","year":"2024"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101219_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.ijmmb.2026.101219_bib4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/v14071504","article-title":"Occult hepatitis B virus infection: an update","volume":"14","author":"Saitta","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101219_bib5","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.35810","article-title":"Hepatitis B reactivation during immunosuppressive therapy or cancer chemotherapy, management, and prevention: a comprehensive review","volume":"16","author":"Tavakolpour","year":"2016","journal-title":"Hepat Mon"},{"issue":"10","key":"10.1016\/j.ijmmb.2026.101219_bib6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S2468-1253(22)00201-1","article-title":"Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis","volume":"7","author":"Im","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.ijmmb.2026.101219_bib7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jiph.2022.11.008","article-title":"Epidemiology of occult hepatitis B and C in Africa: a systematic review and meta analysis","volume":"15","author":"Ondigui","year":"2022","journal-title":"J Infect Public Health"},{"issue":"39","key":"10.1016\/j.ijmmb.2026.101219_bib8","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.3748\/wjg.v22.i39.8720","article-title":"Update on occult hepatitis B virus infection","volume":"22","author":"Makvandi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijmmb.2026.101219_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1130899","article-title":"Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative\/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21","volume":"13","author":"Giordano","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101219_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jceh.2018.06.010","article-title":"INASL Guidelines on management of hepatitis B virus infection in patients receiving chemotherapy, biologicals, immunosupressants, or corticosteroids","volume":"8","author":"Arora","year":"2018","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101219_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2016.08.013","article-title":"Time trends of chronic HBV infection over prior decades - a global analysis","volume":"66","author":"Ott","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijmmb.2026.101219_bib12","series-title":"National action plan combating viral hepatitis in India","year":"2019"},{"key":"10.1016\/j.ijmmb.2026.101219_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfma.2025.11.008","article-title":"Prevalence of seropositive occult hepatitis B virus infection among patients received chemotherapy in Taiwan: a retrospective study","author":"Su","year":"2025","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101219_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1590\/S0004-28032016000300010","article-title":"Prevalence of occult hepatitis B infection in Iranian cancer patients before chemotherapy treatment","volume":"53","author":"Baghbanian","year":"2016","journal-title":"Arq Gastroenterol"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101219_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/ghep.ghep_34_22","article-title":"The burden of occult hepatitis B virus infection in hepatocellular carcinoma in Nigeria","volume":"3","author":"Egboh","year":"2023","journal-title":"Gastroenterology, Hepatology and Endoscopy Practice"},{"key":"10.1016\/j.ijmmb.2026.101219_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mjafi.2016.02.006","article-title":"Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital","volume":"72","author":"Sood","year":"2016","journal-title":"Medical J Arm forces Ind"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101219_bib17","doi-asserted-by":"crossref","DOI":"10.5501\/wjv.v13.i1.89104","article-title":"Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: the CHOICE study","volume":"13","author":"Sudevan","year":"2024","journal-title":"World J Virol"},{"key":"10.1016\/j.ijmmb.2026.101219_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1044098","article-title":"Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: a real-life retrospective single-center cohort study","volume":"13","author":"Lasagna","year":"2023","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ijmmb.2026.101219_bib19","first-page":"403","article-title":"Occult hepatitis B infection among blood donors from Yaound\u00e9, Cameroon","volume":"17","author":"Fopa","year":"2019","journal-title":"Blood Transfusion"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101219_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13104-025-07337-6","article-title":"The status of occult HBV infection in a high endemic region: risk of community HBV transmission and reactivation","volume":"18","author":"Kafeero","year":"2025","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101219_bib21","first-page":"458","article-title":"Screening for occult and overt hepatitis B virus infection in patients of cancer before receiving chemotherapy: looking beyond HBsAg testing","volume":"3","author":"Singh","year":"2015","journal-title":"Int J Adv Res"},{"key":"10.1016\/j.ijmmb.2026.101219_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51157-1","article-title":"Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection","volume":"9","author":"Sinha","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ijmmb.2026.101219_bib23","first-page":"1460","article-title":"Prevalence of Occult Hepatitis B Virus infection in HBsAg negative adult patients with Acute Leukemia in a tertiary care cancer centre in South India","volume":"14","author":"Abraham","year":"2023","journal-title":"J Cardiovas Dis Res"},{"key":"10.1016\/j.ijmmb.2026.101219_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijmmb.2026.101219_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.critrevonc.2015.10.017","article-title":"Hepatitis B and cancer: a practical guide for the oncologist","volume":"98","author":"Bozza","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"10.1016\/j.ijmmb.2026.101219_bib26","doi-asserted-by":"crossref","first-page":"ofy227","DOI":"10.1093\/ofid\/ofy227","article-title":"Occult hepatitis B virus infection: an old entity with novel clinical involvements","volume":"5","author":"Malagnino","year":"2018","journal-title":"Open Forum Infect Dis"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:20:51Z","timestamp":1789201251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085726001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"alternative-id":["S0255085726001787"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101219","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and serological profile of occult hepatitis B virus infection in newly diagnosed cancer patients","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101219"}}